Saturday 17 October 2026 Export AIRS’s income statement to Excel — free account

AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 2.53%, EPS fell 57.0%, free cash flow fell 131.1% and total debt fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.28 0.14 −9.86%

Follow AIRS

Alert me

Market cap: $102.0M
P/E: 0.0×
Fwd P/E: −63.9×
Dividend yield: —
F-score: 3/9
Altman Z: 0.94
Beneish M: −3.34
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 1.80

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	7	4	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 85.22%

Capital & Financial Ratios $m

Market Cap 102.02

Revenue 150.72

Net Income (11.74)

Free Cash Flow 0.76

Net Debt 24.74

Current Ratio 0.79

Debt/Equity 0.42

P/E ratio 0.00

Fwd P/E (63.90)

P/S ratio 0.60

P/B ratio 0.86

Past 5Y EPS Growth —

This Y EPS Growth (60.00%)

Next Y EPS Growth 43.75%

Next Y revenue growth (0.54%)

Next 5Y EPS Growth 11.21%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.56%

10-year low 10-year high

P/B against its own 10 years 0.08%

10-year low 10-year high

EV/Sales against its own 10 years 0.08%

10-year low 10-year high

EV/FCF against its own 10 years 76.41%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	0.00	0.41
2021	Powerpack
2020	Powerpack
2019	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	10	8	8	19
Receivables	2	3	1	2
Inventory	—	—	—	—
Other	—	—	—	—
	16	17	15	27

	2023	2024	2025	Q'26
Payables	4	6	5	7
ST’ Debt	2	4	5	10
Other	—	—	—	—
	20	29	28	35

Compound Annual Growth %

	10y	5y	3y
Sales	—	19.32%	(3.47%)
Cash Flow	—	(26.01%)	(49.78%)
Earnings	—	0.00%	0.00%
Book Value	—	(6.64%)	7.42%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	39	43	—	—	—
’25	39	44	35	33	152
’24	48	51	43	39	180
’23	46	56	47	48	196
’22	40	50	39	41	169
’21	26	35	35	38	133
’20	—	—	18	23	63

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	5	(1)	—	—	—
’25	1	5	0	(3)	3
’24	3	3	2	3	11
’23	6	12	1	5	24
’22	7	10	0	7	24
’21	9	15	9	(6)	27
’20	—	—	—	14	14

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	5	(1)	—	—	—
’25	(1)	5	0	(3)	1
’24	2	(1)	(3)	(1)	(3)
’23	2	10	(1)	3	14
’22	3	9	(4)	4	12
’21	8	13	7	(8)	20
’20	—	—	—	10	10

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.03)	(0.02)	—	—	—
’25	(0.05)	(0.01)	(0.15)	0.02	(0.19)
’24	0.10	(0.06)	(0.10)	(0.09)	(0.14)
’23	0.00	0.03	(0.03)	(0.08)	(0.08)
’22	(0.01)	0.01	(0.13)	(0.13)	(0.26)
’21	—	—	—	—	(0.01)
’20	—	—	—	—	0.14

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	9.83	2.69	3.60	2.92	1.53	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	18.48	17.54	9.94	9.20	12.00
People
People	Employees	—	—	—	—	260	268	302	381	422	363
	Revenue/emp, $m	—	—	—	0.00	0.24	0.50	0.56	0.51	0.43	0.42
Income, $m
Income, $m	Revenue	—	—	—	41	63	133	169	196	180	152
	Gross margin, %	—	—	—	62.44	62.61	66.59	62.81	62.34	60.55	59.37
	EBT	—	—	—	(2)	8	11	(11)	3	(8)	(18)
	EBT margin, %	—	—	—	(5.36)	12.07	8.16	(6.69)	1.65	(4.34)	(11.62)
	Net income	—	0	—	(2)	8	11	(15)	(4)	(8)	(12)
	Depreciation	—	—	—	5	6	7	8	10	12	13
Per share, $
Per share, $	Revenue	—	—	—	0.74	1.13	2.40	3.03	3.45	3.13	2.51
	Earnings	—	—	—	(0.04)	0.14	(0.01)	(0.26)	(0.08)	(0.14)	(0.19)
	Cash flow	—	—	—	0.09	0.25	0.48	0.44	0.42	0.20	0.05
	Capex	—	—	—	(0.08)	(0.07)	(0.13)	(0.23)	(0.17)	(0.24)	(0.04)
	Free cash flow	—	—	—	0.01	0.18	0.35	0.21	0.25	(0.05)	0.01
	Book value	—	—	—	2.16	2.22	1.50	1.27	1.48	1.36	1.45
	Shares, m	—	—	—	56	56	56	56	57	58	60
Valuation, ×
Valuation, ×	P/E	—	—	—	33.81	33.81	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	7.45	7.45	7.17	1.22	2.08	1.66	0.79
	P/B	—	—	—	0.00	0.00	11.45	2.92	4.86	3.83	1.36
	EV/Sales	—	—	—	8.31	8.31	7.60	1.66	2.40	2.03	1.10
	EV/FCF	—	—	—	26.02	26.02	51.94	24.34	33.45	(137.70)	241.75
Cash, $m
Cash, $m	Operating cash flow	—	—	—	5	14	27	24	24	11	3
	Capex	—	—	—	(4)	(4)	(7)	(13)	(10)	(14)	(2)
	Free cash flow	—	—	—	0	10	20	12	14	(3)	1
Balance, $m
Balance, $m	Working capital	—	—	—	(2)	2	13	(6)	(4)	(12)	(12)
	Total debt	—	—	—	33	33	83	84	72	75	56
	Net debt	—	—	—	28	22	57	74	61	66	48
	Shareholders’ equity	—	—	—	120	124	84	71	84	78	88
Returns, %
Returns, %	ROA	—	—	—	(2.58)	4.32	(0.21)	(7.32)	(2.09)	(3.85)	(5.83)
	ROIC	—	—	—	0.28	4.30	7.00	(1.96)	4.18	(0.68)	(5.34)
	ROE	—	—	—	(1.81)	6.21	(0.38)	(19.03)	(5.48)	(9.89)	(14.07)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
AUNA Auna S.A.	$392.3M	76.0×	5.2×	+20.51% (above 0%: growing)	−61.29% (below 0%: shrinking)	+121.08% (above 0%: growing)	35.72%	13.09%	Compare
SRTA Strata Critical Medical, Inc.	$384.0M	9.0×	— (loss-making)	+60.74% (above 0%: growing)	n/m	+150.33% (above 0%: growing)	20.98%	(7.46%)	Compare
AIRS AirSculpt Technologies, Inc.	$102.0M	— (loss-making)	— (loss-making)	−2.53% (below 0%: shrinking)	n/m	−131.07% (below 0%: shrinking)	61.38%	(0.07%)
JYNT The Joint Corp.	$97.7M	26.0×	16.9×	+14.41% (above 0%: growing)	+400.00% (above 0%: growing)	+432.31% (above 0%: growing)	83.68%	(2.43%)	Compare
PARK Park Dental Partners, Inc.	$91.3M	— (loss-making)	—	+12.15% (above 0%: growing)	−65.84% (below 0%: shrinking)	−34.78% (below 0%: shrinking)	14.37%	1.90%	Compare
BTMD biote Corp.	$39.9M	6.8×	11.0×	−9.48% (below 0%: shrinking)	n/m	−174.16% (below 0%: shrinking)	65.38%	(7.93%)	Compare
PIII P3 Health Partners Inc.	$30.1M	— (loss-making)	—	+8.60% (above 0%: growing)	n/m	−272.24% (below 0%: shrinking)	22.26%	10.67%	Compare
CCEL Cryo-Cell International Inc.	$29.4M	— (loss-making)	43.8×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
DCGO DocGo Inc.	$27.9M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)	Compare
Median of peers	$65.6M	17.5×	14.0×	+10.38%	+8.25%	−46.57%	33.12%	(0.26%)

All 55 Medical Care Facilities stocks →

AirSculpt Technologies, Inc. (AIRS) key facts

Concern: AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024.
AirSculpt Technologies, Inc. (AIRS) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, AIRS traded at $1.28, a market capitalization of $102.0 million.
Return on equity was −14.1% and debt-to-equity 0.42.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 0.94 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.